Fig. 3From: Diffuse optical spectroscopic imaging reveals distinct early breast tumor hemodynamic responses to metronomic and maximum tolerated dose regimensMap of oxyhemoglobin flare and regimen-specific response. Interpolated HbO2 maps at baseline (left column) and day 1 (right column) for two pathologic complete responder patients receiving maximum tolerated dose (top) and metronomic (bottom). The tumor region is indicated by the dashed circle with the scale bar indicating 1 cm. The percent change from baseline for the entire tumor region is indicated in the day 1 column showing oxyhemoglobin flare in MTD patient while MET patient showed almost no changeBack to article page